StonvexLoading…
StonvexStonvexStonvexCore line items from HUM's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $1.68B | $5.83B | $4.33B | $2.73B |
Operating Income | $1.75B | $2.70B | $3.51B | $3.11B |
Net Income | $1.19B | $1.19B | $1.98B | $1.79B |
EPS (Diluted) | $9.83 | $9.84 | $16.43 | $14.81 |
Total Assets | $55.28B | $48.91B | $49.72B | $50.36B |
Total Liabilities | $36.63B | $31.17B | $31.14B | $32.06B |
Cash & Equivalents | $4.95B | $4.20B | $5.39B | $4.04B |
Free Cash Flow OCF − CapEx | $1.13B | $375.00M | $2.23B | $1.39B |
Shares Outstanding | 120.65M | 120.83M | 120.78M | 120.79M |